TLDR: In regulated industries the scarce skill is compliance literacy — the judgement to design work that satisfies the rules from the first draft. Employers pay a premium for it because it removes rework, and rework costs far more than salary.
Compliance literacy is judgement inside the role, distinct from the compliance function beside it
Every regulated company already employs people whose job title contains the word compliance. The scarce capability is different: it is the regulatory instinct carried by the scientist, the engineer, the marketer and the commercial lead who never report into that function at all. A compliance-literate professional knows what the applicable rules require, shapes the work to satisfy them before anyone reviews it, and recognises the moment when specialist advice is genuinely needed. That combination is what employers are actually buying when they pay above the market rate.
The distinction shows up most clearly in how work arrives at review. A medical writer without this literacy produces a document that is scientifically sound and then discovers, at review, that a claim exceeds what the label supports and the supporting data set was assembled in a way that cannot be reconstructed. A compliance-literate writer produces a document whose claims are already traceable to the evidence and whose data lineage is documented as it is built. Both writers know the science equally well. Only one of them produces work that survives its first contact with a reviewer.
This capability lives in the design of the work rather than in a checklist applied afterwards, which is why it resists being outsourced to a review gate. Quality control at the end of a process can detect a defect; it cannot recover the six weeks spent building the wrong thing. Regulated work compounds in this respect, because a decision made early — how a study is structured, how consent is captured, how a data pipeline handles personal information — constrains everything downstream and is expensive to unwind once other work depends on it. Literacy is the mechanism that gets those early decisions right.
It also has a boundary, and the best practitioners are precise about it. Compliance literacy is knowing which questions carry regulatory weight and when to escalate them, rather than an attempt to substitute for legal or regulatory expertise. A commercial lead who confidently interprets a novel promotional restriction without consulting anyone is exhibiting the opposite of the trait. Judgement includes knowing the edge of your own competence, and hiring managers should look for that self-awareness as carefully as they look for knowledge.
Defining the capability is the straightforward part, and most senior leaders in regulated industries recognise the description immediately from people they have worked with. Justifying its price to a finance committee is harder, because the value shows up as events that never occurred rather than as outputs that can be counted. A budget holder comparing two candidate salaries sees a difference measured in percentage points and no obvious offsetting line. Making that offsetting line visible is the argument worth having, and it starts with what compliance literacy quietly prevents.
The premium is priced against the cost of rework, which dwarfs the salary line
A salary differential of a few percentage points looks significant on a headcount budget and trivial against the events it prevents. Regulated organisations lose value through delay far more often than through penalty, and delay is precisely the outcome compliance literacy removes most reliably. Framing the premium as insurance against enforcement therefore understates the case considerably, because enforcement is the rare tail event rather than the ordinary one. The stronger argument, and the one finance committees respond to, is that compliance-literate teams reach the market sooner with the same resources.
Consider a submission cycle. A dossier that draws a request for further information from the regulator restarts a clock measured in months, and every month of delay on a commercial product carries revenue that is never recovered rather than merely deferred. The mechanism is exclusivity: patent and data protection periods run from fixed dates regardless of when approval arrives, so a delayed launch permanently shortens the protected selling window. A specialist whose dossiers clear first time therefore returns value that no salary comparison captures, and the effect repeats across every variation and lifecycle change.
Audit findings work the same way. A significant observation from an inspection generates a remediation programme that consumes senior time for months, diverts the same specialists who would otherwise be advancing the pipeline, and frequently triggers a follow-up inspection. The cost concentrates in opportunity rather than in fines: the people best placed to fix the finding are the people whose ordinary work stops while they do it. Teams that build defensible records as a matter of habit avoid the diversion entirely, which is why experienced quality leaders treat inspection readiness as a hiring question rather than a documentation exercise.
There is a second-order effect that rarely appears in a business case and matters greatly in practice. Where a team is trusted to produce compliant work, review becomes proportionate and approvals move quickly; where it is not, the organisation defends itself by adding gates, and every project pays that tax regardless of its actual risk. Hiring for literacy therefore buys velocity across a whole function rather than performance in a single seat. The difficulty is that the people who offer it are genuinely hard to find.
Supply stays short because the regulatory perimeter keeps widening faster than people can be trained
Scarcity in this population is structural rather than cyclical, and the cause is the expanding surface area of regulation itself. Each new instrument extends obligations into roles that previously sat outside the regulated core, so the number of positions requiring literacy grows faster than the pool of people who possess it. Independent market analysis confirms acute shortages across regulatory and specialist roles in the Swiss life-sciences market, and the underlying dynamic applies across the EU and the US.
Medical devices illustrate the mechanism most sharply. The transition from the previous directives to the EU Medical Device Regulation and the In Vitro Diagnostic Regulation raised evidentiary expectations, expanded post-market surveillance obligations and reclassified a substantial share of diagnostics upward, which increased the workload per product and the number of products requiring specialist attention simultaneously. Notified body capacity became the binding constraint, and manufacturers responded by recruiting internally for exactly the profile the notified bodies were also hiring. Demand for the same scarce people rose on both sides of the review relationship.
Data and artificial intelligence have opened a further front that few organisations are staffed for. The GDPR and the revised Swiss Federal Act on Data Protection govern how clinical and commercial data are handled, while the EU AI Act layers obligations onto systems used in health and financial contexts — and a device incorporating machine learning can fall under both device and AI regimes at once. In financial services the equivalent pressure comes from FINMA supervisory expectations extending into conduct, outsourcing and technology risk. The professionals who can operate confidently across two overlapping regimes are correspondingly rare.
Training capacity is the constraint that keeps this from resolving itself. Compliance literacy accumulates through exposure to real submissions, real inspections and real refusals, so the pipeline is limited by the number of experienced practitioners available to develop the next cohort — and those practitioners are precisely the people the market bids away. Organisations that grow their own therefore hold a durable advantage. Whether grown or recruited, the capability still has to be identified, and conventional interviews are poor at it.
| Role family | Instruments they must read fluently | What literacy prevents |
|---|---|---|
| Regulatory affairs, pharma | EMA and Swissmedic procedures, FDA pathways | Requests for further information that reset the submission clock |
| MedTech and diagnostics | MDR, IVDR, notified body expectations | Technical files rejected late in a certification cycle |
| Clinical and data roles | GDPR, revised Swiss FADP, EU AI Act | Data sets that cannot lawfully support the intended analysis |
| Financial services | FINMA supervisory expectations, conduct and outsourcing rules | Supervisory findings and remediation programmes |
| Commercial and medical communication | Promotional codes, label and claim boundaries | Withdrawn materials and lost launch momentum |
Scenario interviews expose the judgement that credentials only imply
Standard interviewing tests recall, and recall is the weakest available proxy for this capability. A candidate who can define a regulation has demonstrated preparation, which any competent professional can complete the night before. A candidate who can navigate a live conflict between commercial pressure and regulatory constraint has demonstrated the thing actually being hired, because that judgement resists rehearsal. Restructuring the interview around decisions rather than definitions costs a hiring team nothing and changes the quality of the signal substantially.
The most revealing format is a realistic scenario with an uncomfortable trade-off built into it. Describe a launch three weeks away, a piece of supporting evidence that turns out to be weaker than assumed, and a country manager who wants to proceed. Strong candidates immediately establish what the claim actually rests on, identify who must be consulted and what the decision record needs to show, and separate the options that are defensible from those that merely feel acceptable. Weak candidates either capitulate to the commercial pressure or refuse without offering a path forward, and both responses are informative.
Probing past decisions in the same way completes the picture. Asking a candidate to describe a time their regulatory judgement proved wrong, and what they changed afterwards, surfaces something a hypothetical cannot: whether experience has actually been metabolised. Practitioners with genuine depth answer this readily and specifically, because refusals and findings are formative events they have already analysed. Candidates who claim never to have misjudged anything are describing a career with limited exposure rather than exceptional accuracy, and hiring teams should read the answer that way.
Involving a regulatory or quality colleague in at least one interview stage improves calibration more than any change to the question set, because a practitioner hears the reasoning behind an answer where a generalist hears only its conclusion. Structured scorecards then help the panel compare candidates on judgement instead of on confidence, which is where unstructured interviews reliably go wrong: the most assured answer and the most defensible one are frequently given by different people. Having identified the capability, the harder commercial problem is holding on to it once competitors recognise it too.
Retention depends on giving the judgement somewhere to go
Compliance-literate professionals are among the most portable people in any regulated organisation, and they are approached constantly by competitors who have reached the same conclusion about their scarcity. Because the capability transfers cleanly between employers and, increasingly, between adjacent sectors, retention rests on the quality of the work rather than on the difficulty of leaving. Counter-offers therefore perform poorly here, since money was rarely the reason the conversation started. Employers who understand this compete on the substance of the role; those who do not discover the market rate through a resignation letter.
The most common cause of departure is being consulted too late. A specialist brought in at the end of a project to approve decisions already taken is being used as a gate, and the work quickly becomes a sequence of arguments they can only lose politely. Bringing the same person into the design phase converts the role from defensive to generative and materially changes how it feels to do. The organisational return is identical to the individual one, since early involvement is also what prevents the rework the premium was paid to avoid.
Continued development matters more here than in most functions, precisely because the perimeter keeps moving. Practitioners who see their expertise depreciating start looking, while those given time to follow guidance changes, attend inspections and take on unfamiliar regulatory territory tend to stay. Structured leadership development compounds this, since the natural progression is from technical judgement towards influencing commercial decisions — a shift that rewards deliberate learning. Edward Galle candidates access HBR-backed training journeys built for exactly that transition.
Visibility is the third lever and the cheapest to pull. When a specialist’s judgement is credited for a submission that cleared first time or an inspection that closed without findings, the organisation signals that the capability is valued rather than merely tolerated — and it teaches the rest of the business what good looks like. Organisations that make prevented problems visible build the internal pipeline that scarcity in the external market makes so valuable.
Edward Galle sources and develops this profile for pharma, MedTech, life sciences and finance employers across Switzerland, the EU and the US. To brief a search, talk to our team about the role oder see how we work with hiring organisations.
References
- Panda International. Swiss Life Sciences Hiring Trends for 2026. https://www.panda-int.com/en-ch/insights/swiss-life-sciences-hiring-trends-for-2026/
- Swiss Financial Market Supervisory Authority (FINMA). https://www.finma.ch/en/
- European Medicines Agency. https://www.ema.europa.eu/en
